The prognosis-associated PANoptosis-related genes (ZBP1, MAP3K7, and RBCK1) were highly elevated in the low-risk group and less expressed in the high-risk group, suggesting the participation of PANoptosis in cancer progression and as a potential target for therapeutic intervention in cancers 115. This evidence concerns the gene MAP3K7 and cancer.